Discover our Portfolio




A definite breakthrough innovation at the crossroads of the industrial and medical worlds, the artificial heart project was possible thanks to the meeting between Matra Défense (Airbus Group) and Professor Alain Carpentier – the success of the research work carried out jointly led to the creation of Carmat in 2008.


Carmat, designer and developer of the world’s most advanced artificial heart project, aims to offer a therapeutic alternative to patients suffering from terminal biventricular heart failure. An innovative leader in revolutionizing the healthcare industry, Carmat is developing a sustainable solution targeting more than 20 million patients in Europe and the United States. Heart failure, the leading cause of death in the world, is a major public health issue. There are very few effective solutions today apart from heart transplantation, which is at the forefront of these solutions.


Carmat’s mission is to become the number one alternative to heart transplantation and to provide innovative technologies that will save lives and improve the quality of life of patients.



Contact Truffle Capital

3 + 15 =

[sg_popup id=2]
5 Rue de la Baume, 75008 Paris, France Tel: +33 1 82 28 46 00



Truffle Capital

Truffle Capital

5 Rue de la Baume 75008 Paris France
Tel: +33 1 82 28 46 00

© 2018 Truffle Capital

Truffle Capital 2018

Social Networks